Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial)

BACKGROUND: Mortality rates in the Intensive Care Unit and subsequent hospital mortality rates in the UK remain high. Infections in Intensive Care are associated with a 2–3 times increased risk of death. It is thought that under conditions of severe metabolic stress glutamine becomes "condition...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrews, Peter JD, Avenell, Alison, Noble, David W, Campbell, Marion K, Battison, Claire G, Croal, Bernard L, Simpson, William G, Norrie, John, Vale, Luke D, Cook, Jonathon, de Verteuil, Robyn, Milne, Anne C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082027/
https://www.ncbi.nlm.nih.gov/pubmed/17883854
http://dx.doi.org/10.1186/1745-6215-8-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082027/
https://www.ncbi.nlm.nih.gov/pubmed/17883854
http://dx.doi.org/10.1186/1745-6215-8-25

Ejemplares similares